Combined targeting of GPX4 (e.g., via GSH replenishment) and FSP1 (e.g., using CoQ10 analogs like idebenone) may offer synergistic benefits in mitigating sepsis-induced ferroptosis. Here, GPX4 is linked to Sepsis.